GSTM1 and breast carcinoma: Lee et al.,5 in a study evaluating the effect of Hb level with survival outcomes in patients with breast cancer, showed that Hb level was the highest at the beginning of the 1-year period following treatment and then gradually decreased to 12.0 mg/dL at the end of the 1-year period.